Decoding CD24: Roles of chemoradiotherapy resistance and potential as therapeutic targets [0.03%]
解码CD24：化疗和放疗耐药的作用及作为治疗靶点的潜力
Y U Hong,Yunxiang Tang,Wenyan Zhou et al.
Y U Hong et al.
As a rising immune checkpoint on tumor cells, CD24 is closely related to tumorigenesis and progression. CD24 can directly regulate the malignant behavior of tumor cells and indirectly inhibit the function of immune cells in the meantime, wh...
Advances and challenges in leukemia treatment: A focus on monoclonal antibodies and emerging therapies [0.03%]
白血病治疗的进展与挑战：单克隆抗体和新兴疗法为重点
Giovana Gomes Chagas,Ruan Pimenta,Nayara Izabel Viana
Giovana Gomes Chagas
The monoclonal antibodies consist of an innovative form of immunotherapy, capable of defeating several diseases, such as cancer. It is an emergent and important theme, that advances evaluation, challenges, and future perspectives with high ...
Hypoxia-induced exosomal lncRNA-PVT1 as a biomarker and mediator of EMT in hepatocellular carcinoma [0.03%]
缺氧诱导的肝癌细胞来源外泌体长链非编码RNA-PVT1作为上皮间质转化标志物及调控因子的作用机制研究
Libo Liang,Xinyi Wang,Yuping Zeng et al.
Libo Liang et al.
Objectives: Exosomal long noncoding RNAs (lncRNAs) might facilitate epithelial-mesenchymal transition (EMT) in liver cancer after transarterial chemoembolization (TACE), thereby enhancing tumor cell invasiveness and migra...
Correction: LncRNA PCGEM1 facilitates cervical cancer progression via miR-642a-5p/KIF5B axis [0.03%]
Correction：长链非编码RNA PCGEM1通过miR-642a-5p/KIF5B轴促进宫颈癌进展
Yuanlin Liu,Yan Liu,Yan Wang et al.
Yuanlin Liu et al.
[This corrects the article DOI: 10.32604/or.2024.047454.]. © 2025 The Authors.
Published Erratum
Oncology research. 2025 May 29;33(6):1505. DOI:10.32604/or.2024.056768 2025
Is miR-10a a tumor suppressor that modulates proliferation and invasion in high-grade bladder cancer? [0.03%]
MiR-10a是否通过调控增殖和侵袭抑制高级别膀胱癌的发生？
THAINá Rodrigues,PATRíCIA Candido,Feres Camargo Maluf et al.
THAINá Rodrigues et al.
Objectives: Bladder Cancer (BC) is one of the most commonly diagnosed malignancies worldwide, with high rates of mortality and morbidity. It can be classified as non-muscle invasive bladder cancer (NMIBC) or muscle-invasi...
Apatinib modulates sorafenib-resistant hepatocellular carcinoma through inhibiting the EGFR/JNK/ERK signaling pathway [0.03%]
阿帕替尼通过抑制EGFR/JNK/ERK信号通路调控索拉非尼耐药的肝癌干细胞簇
Dexue Fan,Wei Su,Zhaowen Bi et al.
Dexue Fan et al.
Objectives: Apatinib has been reported to be a promising treatment for sorafenib-resistant hepatocellular carcinoma (HCC) patients. However, the underlying mechanism remains ambiguous. The study aimed to explore the effic...
Current status, hotspots, and trends in cancer prevention, screening, diagnosis, treatment, and rehabilitation: A bibliometric analysis [0.03%]
癌症预防、筛查、诊断、治疗和康复的现状、热点及趋势：文献计量分析
Chuchu Zhang,Ying Liu,Zehui Chen et al.
Chuchu Zhang et al.
Objectives: Decades of clinical and fundamental research advancements in oncology have led to significant breakthroughs such as early screening, targeted therapies, and immunotherapy, contributing to reduced mortality rat...
Multimodal omics analysis of the EGFR signaling pathway in non-small cell lung cancer and emerging therapeutic strategies [0.03%]
非小细胞肺癌表皮生长因子受体信号通路的多模态组学分析及新的治疗策略
Yuzheng Li,Lili Yu,Shiyao Zhou et al.
Yuzheng Li et al.
Background: Non-small cell lung cancer (NSCLC) involves complex alterations in the epidermal growth factor receptor (EGFR) signaling pathway. This study aims to integrate multimodal omics analyses to evaluate and enhance ...
Ashutosh Kumar Maurya,Anjali Sangeeth,Rabina Punathil et al.
Ashutosh Kumar Maurya et al.
Carcinogenesis is a multilevel process characterized by genetic and epigenetic alterations, thus contributing to uncontrolled proliferation that eventually leads to cancer. The process of carcinogenesis involves an intricate dis-orchestrati...
Retraction: Triptolide inhibits proliferation and migration of human neuroblastoma SH-SY5Y cells by upregulating microRNA-181a [0.03%]
撤回：三氟拉宁通过上调微小RNA-181a抑制人神经母细胞瘤SH-SY5Y细胞的增殖和迁移
Oncology Research Editorial Office
Oncology Research Editorial Office
[This retracts the article DOI: 10.3727/096504018X15179661552702.]. © 2025 The Author.